Seite - 18 - in Cancer Nanotheranostics - What Have We Learnd So Far?
Bild der Seite - 18 -
Text der Seite - 18 -
Condeetal. Biofunctionalizationandsurfacechemistryof inorganicnanoparticles
FIGURE6 |Quantumdotproteinbiosensors. (A)Schematic showing the
commondesign, chemical andsensingelements, includingFRET-based
biosensors: (1)peptidemodularity, (2)peptide labeling, (3)attachment toQDs,
and (4)FRET-basedsensingforboththecaspase3proteolyticsensor (left)and
Ca2+ sensor (right). The4-pendant carboxyl groups that interactwithCa2+
ionsareshown in redon theCaRbCl structure.Within theCa2+ sensor
peptidesequence,Aib is thesynthetic aminoacidα-aminoisobutyric acid.
Reactivedyestructuresareshownwhereappropriatealongwith thechemical
linkagesattaching themto thepeptides. (B)Representative, superimposed
spectracollectedfrom550nmemittingQDdonorssurfacefunctionalizedwith
85:15DHLAPEG600-COOH/DHLA-PEG750-OMe ligandsandcovalently
conjugated to increasingmolar ratiosofTexasRed-labeledsubstratepeptide. Samplesexcitedat350nm. (C)Proteolytic assaydata fromexposinga
constant concentrationof550nmemittingQDsconjugated to4TexasRed
substratepeptides toaconstantconcentrationofcaspase3enzyme.Derived
KmandVmaxvaluesaregiven.AnR2=0.98wasobtained for thefittingof
thecurve. (D)Representative, superimposed, anddeconvolutedspectra
collected from580nmemittingQDdonorsself-assembledwith increasing
CaRbCl-acceptor labeledpeptides.Sampleswereexcitedat350nm.
(E)Normalizedacceptor/donorPLarea ratios for580nmQDsself-assembled
with∼2CaRbCl-acceptor labeledpeptidesexposed toselected ionic
materials. The ratio fromthenativeunexposedsensorwasset toan initial
valueof1 for comparisonpurposes (Prasuhnet al., 2010).Reproducedwith
permission fromPrasuhnet al. (2010),Copyright2013.
When using enzyme-based biosensors the main concern is
reusability of the enzyme. Khoshnevisan et al. reported the use
ofMNPs to circumvent this dilemmawhenusing cellulase. The
enzymewas incubatedwith theMNPsandbindingconfirmedby FT-IR.The authors show that immobilization grants higher sta-
bility totheenzyme, thusconfirmingthat theuseofMNPsinthis
type of biosensors can be of great benefit (Khoshnevisan et al.,
2011).
www.frontiersin.org July2014 |Volume2 |Article48 | 18
Cancer Nanotheranostics
What Have We Learnd So Far?
- Titel
- Cancer Nanotheranostics
- Untertitel
- What Have We Learnd So Far?
- Autoren
- João Conde
- Pedro Viana Baptista
- Jesús M. De La Fuente
- Furong Tian
- Herausgeber
- Frontiers in Chemistry
- Datum
- 2016
- Sprache
- englisch
- Lizenz
- CC BY 4.0
- ISBN
- 978-2-88919-776-7
- Abmessungen
- 21.0 x 27.7 cm
- Seiten
- 132
- Schlagwörter
- Nanomedicine, Nanoparticles, nanomaterials, Cancer, heranostics, Immunotherapy, bioimaging, Drug delivery, Gene Therapy, Phototherapy
- Kategorien
- Naturwissenschaften Chemie